Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, October 25, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Avilar Therapeutics Increases Financing to $75 Million to Advance Pipeline of Novel Extracellular Protein Degraders
Life Sciences Times
-
February 16, 2023
0
Venture Capital
Robigo Secures $7M Seed Round to Protect Crops from Untreatable Diseases
Life Sciences Times
-
February 16, 2023
0
Venture Capital
Aera Therapeutics Launches with $193 Million in Financing to Enable and Advance the Next Generation of Transformative Genetic Medicines
Life Sciences Times
-
February 16, 2023
0
Venture Capital
Waters Corporation to Acquire Wyatt Technology, Light Scattering Instrument and Software Leader
Life Sciences Times
-
February 15, 2023
0
Venture Capital
Ivy Fertility Acquires Fertility Associates of Memphis
Life Sciences Times
-
February 14, 2023
0
Venture Capital
MDI Health Raises $20 Million Series A to Tackle Medication-Related Problems
Life Sciences Times
-
February 14, 2023
0
Venture Capital
Insulet Acquires Assets of Automated Glucose Control LLC (AGC)
Life Sciences Times
-
February 14, 2023
0
Venture Capital
Henry Schein Announces $400 Million Share Repurchase Plan
Life Sciences Times
-
February 13, 2023
0
Venture Capital
RQM+ Acquires Giotto Compliance
Life Sciences Times
-
February 9, 2023
0
Venture Capital
Allurion, a Global Leader in Weight Loss Technology, to Become Publicly Listed Through Business Combination With Compute Health Acquisition Corp.
Life Sciences Times
-
February 9, 2023
0
Venture Capital
Reshape Bio Raises $8 Million to Automate Experimental Tasks and Build New Infrastructure for Food, Agriculture and Microbial Research
Life Sciences Times
-
February 9, 2023
0
Venture Capital
Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform
Life Sciences Times
-
February 9, 2023
0
1
...
50
51
52
...
115
Page 51 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026